Clinical trial / 2013
Coffee consumption reduced oxidative damage and increased telomere length in hepatitis C patients.
Forty patients with chronic hepatitis C participated in a randomized crossover trial comparing four cups of coffee daily for 30 days against coffee abstinence. During the coffee period, 8-hydroxydeoxyguanosine (15 ± 3 vs 44 ± 16 8-hydroxydeoxyguanosine/10^5 deoxyguanosine, p = 0.05) and collagen levels (56 ± 9 vs 86 ± 21 ng/mL, p = 0.04) were significantly lower than during abstinence. Telomere length was significantly greater with coffee intake (0.68 ± 0.06 vs 0.48 ± 0.04 Arbitrary Units, p = 0.006).
- Study type
- Randomized crossover trial
- Who was studied
- 40 patients with chronic hepatitis C
- What was measured
- Oxidative stress, telomere length, and collagen levels
THE PAPER
Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial.
Cardin R, Piciocchi M, Martines D, Scribano L, Petracco M, Farinati F. Dig Liver Dis, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.